These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 7016449

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD.
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [Abstract] [Full Text] [Related]

  • 6. Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis.
    Eyssette M, Rohmer F, Serratrice G, Warter JM, Boisson D.
    Curr Med Res Opin; 1988 Nov; 10(10):699-708. PubMed ID: 3286128
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An approach to switching patients from baclofen to tizanidine.
    Brenner R, Hyman N, Knobler R, O'Brien M, Stephan T.
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [Abstract] [Full Text] [Related]

  • 9. The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen.
    Stien R, Nordal HJ, Oftedal SI, Slettebø M.
    Acta Neurol Scand; 1987 Mar; 75(3):190-4. PubMed ID: 3554879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
    Wallace JD.
    Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients.
    Hoogstraten MC, van der Ploeg RJ, vd Burg W, Vreeling A, van Marle S, Minderhoud JM.
    Acta Neurol Scand; 1988 Mar; 77(3):224-30. PubMed ID: 3376747
    [Abstract] [Full Text] [Related]

  • 16. Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis.
    Bass B, Weinshenker B, Rice GP, Noseworthy JH, Cameron MG, Hader W, Bouchard S, Ebers GC.
    Can J Neurol Sci; 1988 Feb; 15(1):15-9. PubMed ID: 3345456
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A.
    Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.